<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863097</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.836</article-id><article-id pub-id-type="other">EPV0033</article-id><article-id pub-id-type="pii">S0924933824008368</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>HCV screening, investigation and management in persons with SUD admitted to Mount Carmel Hospital, Malta</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Apap Bologna</surname><given-names>M. A.</given-names></name><xref rid="aff1991" ref-type="aff"/><xref rid="cor0697" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sant</surname><given-names>K.</given-names></name><xref rid="aff1991" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Camilleri</surname><given-names>A.</given-names></name><xref rid="aff1991" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Grech</surname><given-names>G.</given-names></name><xref rid="aff1991" ref-type="aff"/></contrib></contrib-group><aff id="aff1991"><institution>Mount Carmel Hospital</institution>, <city>Attard</city>, <country>Malta</country></aff><author-notes><corresp id="cor0697"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="811">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S406</fpage><lpage>S406</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824008368a.pdf"/><abstract><sec id="sec4190"><title>Introduction</title><p>Individuals who suffer from substance use disorder (SUD) are at increased risk of Hepatitis C (HCV). Mount Carmel Hospital (MCH) is the only public service in-patient mental health care facility on the island of Malta.&#x000a0;Individuals with SUD are referred to MCH for support with comorbid mental health conditions.</p></sec><sec id="sec4191"><title>Objectives</title><p>To assess whether current practice meets the UK Clinical Guidelines on Drug Misuse and Dependence (2017) recommendations- yearly screening for HCV, further testing and referral to infectious disease specialists for those who screen positive for HCV. To compare current practice at MCH, Malta with other countries in the European Union and United Kingdom.</p></sec><sec id="sec4192"><title>Methods</title><p>Retrospective analysis of HCV screening, investigation and referral practices as recorded on iSoft Clinical Manager records for SUD-related admissions to MCH under the care of addiction specialists in 2022 (n=120). Admissions data were provided by the data protection office, with permission from the Chairman of the Department of Psychiatry, and de-identified at source to safeguard patient confidentiality.</p></sec><sec id="sec4193"><title>Results</title><p>60% (n=72) of the SUD inpatient population underwent screening for HCV according to guideline recommendations. 37% (n=44) of this cohort has received a positive HCV antibody result. 32 persons had HCV RNA load records, 34% (n=11) of whom had a detectable viral load. 50% (n=17) of those who screened positive for HCV were offered an appointment with an infectious disease specialist within the year, 7 attended. The table below compares HCV status between our group and published data for the UK, Austria and Greece. Despite heterogeneity in study designs and populations (we describe an inpatient cohort with diagnosed SUD, not all of whom inject drugs) comparable proportions have undergone HCV screening in the preceding twelve months and similar proportions have chronic HCV infection.<table-wrap position="anchor" id="tab1"><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">% Tested in past year for HCV</th><th align="center" valign="middle" rowspan="1" colspan="1">% HCV antibody positive</th><th align="center" valign="middle" rowspan="1" colspan="1">% HCV RNA detectable</th><th align="center" valign="middle" rowspan="1" colspan="1">% HCV cleared</th></tr></thead><tbody><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Malta (MCH 2022)</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="middle" rowspan="1" colspan="1">34</td><td align="center" valign="middle" rowspan="1" colspan="1">66</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">England, Wales, N. Ireland 
(UAMS 2021)</td><td align="center" valign="middle" rowspan="1" colspan="1">43</td><td align="center" valign="middle" rowspan="1" colspan="1">57</td><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">74</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Scotland (NESI 2020)</td><td align="center" valign="middle" rowspan="1" colspan="1">58</td><td align="center" valign="middle" rowspan="1" colspan="1">55</td><td align="center" valign="middle" rowspan="1" colspan="1">81</td><td align="center" valign="middle" rowspan="1" colspan="1">19</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Austria (EMCDDA 2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">59</td><td align="center" valign="middle" rowspan="1" colspan="1">85</td><td align="center" valign="middle" rowspan="1" colspan="1">44</td><td align="center" valign="middle" rowspan="1" colspan="1">56</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Greece (EMCDDA 2019)</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">61</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">46</td></tr></tbody></table><graphic xlink:href="S0924933824008368-TABU0001" position="anchor"/></alternatives></table-wrap>
</p></sec><sec id="sec4194"><title>Conclusions</title><p>Most SUD inpatients at MCH undergo HCV screening according to guideline recommendations but current practice falls short of ideal coverage and follow-up care. Current screening practices and chronic HCV infection rates at MCH are comparable to other countries in the EU and UK.</p></sec><sec id="sec4195"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>